ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025

Company granted key U.S. patent on BE-Smart Esophageal Adenocarcinoma Risk Assessment test (August 2025) ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company to hold a virtual conference call Wednesday, August 13, 2025, at 2:00 PM ET UNIONDALE, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company" or "ProPhase") a diversified diagnostics, genomics, a ...